Distributed by Mapi Research Trust
Distributed by Mapi Research Trust
Developed in 2007
The European Restless Legs Syndrome Study Group (EURLSSG)
Restless Legs Syndrome
PRO
García-Borreguero D, et al. Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome. Sleep Med. 2007 Aug;8(5):455-63 (PubMed abstract)
The European Restless Legs Syndrome Study Group (EURLSSG)
Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66
If you do not receive specific funding for your study, you may download the questionnaire directly:
Tutorials are available on our FAQs.
All requests have to be submitted through our online request management:
| ROYALTY FEES* | Commercial users | Cost per study | Between 3 500 € and 25 000 € (depending on the number of patients included in the study) |
| Cost per language | Free | ||
| Funded academic research | Cost per study | Free | |
| Cost per language | Free | ||
| Not funded academic users | Cost per study | Free | |
| Cost per language | Free |
| DISTRIBUTION FEES* | Commercial users | Cost per study | 700 € |
| Cost per language | 300 € | ||
| Funded academic research | Cost per study | 300 € | |
| Cost per language | 50 € | ||
| Not funded academic users | Cost per study | Free | |
| Cost per language | Free |
* Excluding VAT
Commercial users: Industry, CRO, any for-profit companies
Funded Academic research: Projects receiving funding from commerce, government, EU or registered charity. Funded academic research– sponsored by industry fits the “commercial users” category.
Not funded academic users, individual medical practice: Projects are not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds
|
Transfer of rights to use and reproduce the Questionnaire (Owner’sRoyalty Fees) |
COMMERCIAL USERS Cost per study based on the number of patients included in the study: |
less than 50 PATIENTS: |
3 500 Euros* |
From 50 to 199 PATIENTS: |
7 000 Euros* |
||
From 200 to 499 PATIENTS: |
15 000 Euros* |
||
From 500 to 999 PATIENTS: |
20 000 Euros* |
||
More than 1.000 PATIENTS: |
25 000 Euros* |
||
FUNDED ACADEMIC RESEARCH |
COST PER STUDY |
n/a |
|
COST PER LANGUAGE |
n/a |
||
MRT’s Distribution Costs |
COMMERCIAL USERS |
COST PER STUDY |
700 Euros* |
COST PER AVAILABLE LANGUAGE |
300 Euros* |
||
FUNDED ACADEMIC USERS |
COST PER STUDY |
300 Euros* |
|
COST PER AVAILABLE LANGUAGE |
700 Euros* |
||
NOT FUNDED ACADEMIC USERS |
COST PER STUDY |
n/a |
|
COST PER AVAILABLE LANGUAGE |
n/a |
* Excluding VAT
Additional information on the EURLSSG website
Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.
Should you not correspond to this category of users, please send us a request.
Note: This site aims at providing you with the original version and existing translations of the questionnaire. However some modules/versions may not be downloadable in the language you need.
If you are interested in specific language(s), please first consult the list of existing translations in PROQOLID.
To access this section, please complete a client account.
The translations listed may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.
The author has selected Mapi as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.
For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).
If you wish to translate the questionnaire:
Subscribe to PROQOLID™
And get access to advanced descriptions of Clinical Outcome Assessments (COAs)!
SubscribePurchase a limited access to this COA instrument page
This will allow you to view this specific COA page during one active session of 12 hours max starting at your first attempt. Note that if your session is inactive for four hours, your access will be closed.